Am J Transplant, Volume 17, Suppl 3 Archives - Page 147 of 181 - ATC Abstracts

2017 American Transplant Congress
Prospective DSA Monitoring and Significance of De Novo DSA in Adult Liver Transplantation.
S. Kubal,¹ R. Mangus,¹ J. Fridell,¹ B. Ekser,¹ R. Saxena,² N. Rush,² N. Higgins,⁴ M. Ghabril,³ M. Lacerda,³ A. Lobashevsky.⁴
¹Department of Surgery, Division of Transplantation, Indiana University School of Medicine, Indianapolis, IN; ²Department of Pathology, Indiana University School of Medicine, Indianapolis, IN; ³Department of Gastroenterology, Division of Hepatology, Indiana University School of Medicine, Indianapolis, IN; ⁴Department of Medicine, Immunology/Histocompatibility Laboratory, Indiana University School of Medicine, Indianapolis, IN
Background: Post transplant course of circulating de novo donor specific antibodies (DSA) remains unknown after liver transplantation (LT).Methods: In a prospective study, sera from 92…
2017 American Transplant Congress
Steroid-Free Immunosuppression After Liver Transplant for Autoimmune Disease Does Not Result in Increased Disease Recurrence.
A. Hooper,¹ C. Frenette.²
¹Internal Medicine, Scripps Mercy Hospital, San Diego, CA; ²Organ Transplant, Scripps Green Hospital, La Jolla, CA
Immunosuppression regimens in patients with end stage liver disease (ESLD) from autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) typically include…
2017 American Transplant Congress
Sensitized KPD Pairs Take Longer to Find Matches.
C. Holscher,¹ E. Chow,¹ C. Purcell,² M. Ronin,² J. Garonzik-Wang,¹ A. Massie,¹ S. Gentry,³ D. Segev.¹
¹Johns Hopkins University, Baltimore; ²National Kidney Registry, New York; ³US Naval Academy, Annapolis
Kidney paired donation (KPD) can facilitate living donor transplantation for candidates with an incompatible donor, but it is unclear how sensitization or blood type affects…
2017 American Transplant Congress
African American Living Kidney Donors' Attitudes About APOL1 Genetic Testing: Implications for Evaluation and Informed Consent.
E. Gordon,¹ C. Johnson,¹ C. Wicklund,¹ R. Sharp,² J. Friedewald.¹
¹Northwestern University, Chicago, IL; ²Mayo Clinic, Rochester
BackgroundAfrican American (AA) live kidney donors (LKDs) have a greater risk than European American live donors of kidney failure. Apolipoprotein 1 (APOL1) gene variants in…
2017 American Transplant Congress
Effect of AKI Donor Admit Creatinine on Renal Transplant Outcomes.
E. Giorgakis,¹ R. Heilman,² H. Khamash,² B. Kaplan,² A. Moss,¹ M. Smith,³ K. Reddy.¹
¹Department of Surgery, Mayo Clinic, Phoenix, AZ; ²Department of Medicine, Mayo Clinic, Phoenix, AZ; ³Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
Purpose of the study was to explore the effect of admit AKI donor creatinine on graft outcomes.Method: Single center retrospective analysis of kidney transplants performed…
2017 American Transplant Congress
Screening and Referral of High Risk Liver Transplant Recipients to a Transitional Care Coordination (TCC) Program to Reduce Hospital Readmissions.
A. Masoumi,¹ J. Krzyzewski,¹ T. Stern,¹ N. Schluterman,² D. Bruno,² J. Bromberg,² R. Barth,² S. Hanish.²
¹University of Maryland Medical Center, Baltimore, MD; ²University of Maryland School of Medicine, Baltimore, MD
Introduction One-fifth of Medicare patients are readmitted to the hospital. The readmission rate among liver transplant recipients at a large tertiary academic medical center in…
2017 American Transplant Congress
Pre-Kidney Transplant Lower Extremity Impairment and Post-Transplant Mortality.
A. Nastasi,^1,2 M. McAdams-DeMarco,^1,2 J. Schrack,¹ H. Ying,² C. Haugen,² M. González Fernández,³ D. Segev.^1,2
¹Epidemiology, Johns Hopkins University, Baltimore, MD; ²Surgery, Johns Hopkins University, Baltimore, MD; ³Physical Medicine and Rehabilitation, Johns Hopkins University, Baltimore, MD
INTRODUCTION. Few objective tests can be easily performed prior to kidney transplantation (KT) to effectively stratify patients by risk of post-KT mortality. The short physical…
2017 American Transplant Congress
EXPANDER-1: Exploring Renal Transplants Using Hepatitis-C Infected Donors for HCV-Negative Recipients.
C. Durand, D. Brown, R. Wesson, N. Bhair, F. Naqvi, D. Ostrander, M. Bowring, A. Massie, S. Rasmussen, J. Sugarman, D. Segev, M. Sulkowski, N. Desai.
JHU, Baltimore, MD
Kidneys from hepatitis C-infected (HCV+) donors are underutilized in an era of severe organ shortage. In an effort to expand the donor pool, we evaluated…
2017 American Transplant Congress
TACI Polymorphisms Associated with De Novo Alloantibodies in Humans and Allograft Rejection in Mice.
J. Platt,¹ E. Farkash,² A. Lefferts,¹ M. Samaniego,³ M. Cascalho.¹
¹Surgery, University of Michigan, Ann Arbor, MI; ²Pathology, University of Michigan, Ann Arbor, MI; ³Internal Medicine, University of Michigan, Ann Arbor, MI
A. Trans-membrane Activator and CAML Interactor (TACI) controls B cell differentiation and memory and exists as numerous allelic variants among healthy individuals and individuals with…
2017 American Transplant Congress
Minimal Effect of Broader Heart Sharing on Regional Outcomes.
A. Bitar,¹ M. Skeans,² R. Davies,³ M. Farr,⁴ A. Kao,⁵ L. Robbins-Callahan,⁶ J. Rogers,⁷ S. Silvestry,⁸ M. Colvin.^1,2
¹U of MI, Ann Arbor, MI; ²SRTR, Mpls, MN; ³Nemours/AIDHC, Wilmington, DE; ⁴Columbia U, NY, NY; ⁵Mid-America Heart Inst, KC, MO; ⁶UNOS, Richmond, VA; ⁷Duke U, Durham, NC; ⁸FL Hosp Transplant Inst, Orlando, FL
The OPTN/UNOS Heart Subcommittee proposed a revision to policy 6 (Allocation of Hearts and Heart-Lungs) to better address heart transplant candidate medical urgency. They developed…